Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Students for Life: Abortion pill review ‘must go back to the beginning’ Anti-abortion ...

Fewer people had abortions in the first half of 2025 in states that allow the procedure, a report found, marking the first such decline in the three years since Roe v. Wade was overturned.

A Texas federal judge transferred a lawsuit seeking to restrict the availability of abortion pill mifepristone to a court in Missouri rather than ending it outright after finding that it no longer had ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that the FDA would conduct a new safety review of commonly used abortion pills. The announcement sparked immediate outrage ...

Louisiana Attorney General Liz Murrill said it's "dangerous, irresponsible, unethical, and illegal to distribute these pills" in the stateNEED TO KNOWThe state of Louisiana issued an arrest warrant ...

A Texas federal judge late Tuesday declined to dismiss a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone, instead transferring the case to ...

The drug pricing vibe check: Many big companies think it could be much worse. Art of the deal: Pfizer’s drug pricing deal with the Trump administration could have been much worse for other big players ...

Melanie Israel is a visiting fellow at the DeVos Center for Life, Religion, and Family at The Heritage Foundation. On Sept. 28, 2000, the Food and Drug Administration approved the abortion pill ...

A federal judge in Texas declined to dismiss a suit against the Food and Drug Administration that would restrict mifepristone, an abortion pill. U.S.

You’ve read Amarillo Tribune articles this month! Thank you for relying on us for your local news. Please help us keep local news free for all by donating today! On Tuesday, Judge Matthew Kacsmaryk of ...

The FDA's new review of mifepristone's safety could lead to changes in and limits on its prescription, but experts believe an outright ban is unlikely. HealthDay News — The U.S. Food and Drug ...

Providers of abortion and other reproductive health care services should consider key issues and risks in the current legal landscape, as impacted by the US Supreme Court’s decision in Dobbs v.